ArticleNPJ breast cancer2025

Basal-like HR + /HER2- breast cancers show higher tumor-infiltrating lymphocytes and immune signatures with potential therapeutic implications.

Gaia Griguolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.